ClinicalTrials.gg
RecruitingNCT06880302MARKUpdated Jun 2, 2026

Male Infertility and Assisted Reproductive Technologies Research Biobank

An observational study in Male Infertility and Infertility (IVF Patients), sponsored by Reproductive Medicine Associates of New Jersey. Recruiting at 1 site in United States. Open to male participants. Per ClinicalTrials.gov, last updated 2026-06-02.

Sponsored by Reproductive Medicine Associates of New Jersey · Observational

From the registry’s dates

  • Started Mar 2025; still recruiting 1 year 8 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,000
Sex
Male
01

Study summary

The objective of this research is to build a biobank of biological male specimens used for diagnostics and treatment of infertility or assisted reproductive technologies (ART).

Read the detailed description

The objective of this research is to build a biobank of biological male specimens used for diagnostics and treatment of infertility or assisted reproductive technologies (ART). These specimens include testicular tissue, sperm, semen samples, donor sperm or discarded sperm preps. These samples were possibly utilized for diagnostic testing such as semen analyses or DNA fragmentation testing or for ART procedures such as intrauterine insemination (IUI) in-vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) and are no longer needed clinically. Rather than discarding those samples the men who provided them or the sperm recipient in the case of donor sperm may elect to donate them for future research purposes. These samples will be used for future research regarding male infertility and assisted reproductive technologies.

02

Conditions studied

  • Male Infertility
  • Infertility (IVF Patients)
03

In context

Infertility, Male

282 studies on the registry are indexed under Infertility, Male; 65 are open to participants now.

This study's planned enrollment of 1,000 is above the median of 182 across 87 observational studies indexed under Infertility, Male.

Browse Infertility, Male studies →

Lead sponsor

Reproductive Medicine Associates of New Jersey is the lead sponsor of 55 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Male
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Males that had previously provided male biological specimen for their infertility treatment that no longer wishes to keep their samples frozen

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Males providing testicular tissue, sperm, semen samples, discarded sperm preps for IUI/IVF/ICSI or the sperm recipient for those utilizing donor sperm, for cryopreservation at the respective site(s) for either clinical use or preservation

Exclusion criteria

Exclusion Criteria:

  • Samples that are quarantined or in isolation dewars for infectious diseases
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,000 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • Males providing specimen for infertility treatment

    Males providing specimen for infertility treatment

06

What researchers measure

Primary outcomes

  1. Biobank

    The purpose of this study is to create a biobank of male biological specimens

    Time frame: 5 years

07

Study locations

1 of 1 sites recruiting
  • RMANJ
    Basking Ridge, New Jersey 07920, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06880302
Lead sponsor
Reproductive Medicine Associates of New Jersey
Responsible party
Sponsor
First posted
Mar 17, 2025
Start date
Mar 4, 2025
Primary completion
Apr 2032 (estimated)
Completion
Dec 2032 (estimated)
Last update
Jun 2, 2026

Study contacts

Caroline Zuckerman, RN BSN
Contact
clinicalresearchteam@ivirma.com
9736562841
Christine Whitehead, MS, BSN, RN
Contact
clinicalresearchteam@ivirma.com
9736562841

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion